Global Anorectal Disorders Treatment Market Segmentation, By Disease (Diarrhea, Hemorrhoid, Abscesse, Fistula, Itching, Fissures, Rectal Prolapse, Warts, Others), Treatment (Drugs, Surgery, Others), Route of Administration (Oral, Parenteral, Rectal, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) - Industry Trends and Forecast to 2032
Anorectal Disorders Treatment Market Analysis
From the name itself, it is clear that anorectal disorders are medical disorders that occur or develop in the rectum or the anal canal. Rectal bleeding, hemorrhoids, fissures, and polyps are the common causes of anorectal disorders. The anorectal disorders can lead to excessive pain, itching and swelling around the anus and rectum and cause discomfort.
Anorectal Disorders Treatment Market Size
Global anorectal disorders treatment market size was valued at USD 4.30 billion in 2024 and is projected to reach USD 7.44 billion by 2032, with a CAGR of 7.10% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes
|
Anorectal Disorders Treatment Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Key Market Players
|
AKORN INC., Novartis AG, Mylan N.V., GlaxoSmithKline plc., Ferndale Pharma Group, Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, AstraZeneca, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., NATCO Pharma Limited, LUPIN, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, AbbVie Inc., Allergan, Aboott and Bayer AG
|
Anorectal Disorders Treatment Market Dynamics
Drivers
- Growing prevalence of disorders
Rising incidence rate of gastrointestinal related disorders, inflammatory bowel diseases and family history of diseases and disorders such as cancer can lead to the development of anorectal disorders. This in turn would create huge demand for effective, efficient and advanced medical treatment for anorectal disorders.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the market's growth rate is the rising healthcare expenditure, which helps in improving its infrastructure. Growth and expansion of healthcare industry especially in the developing economies would invite the use and application of new and advanced medial technologies, equipment and drugs. This will directly increase the demand for anorectal disorders treatment.
- Research and development activities
Growing number of strategic collaboration between public and private market players is inducing growth in the number of research and development activities on daily basis. These research and development proficiencies are being conducted in novel drugs and medical technologies that will propel the demand for anorectal disorders treatment.
Furthermore, presence of strong pipeline for antiviral drugs, rising geriatric population base and increasing prevalence of congenital problems such as vacterl, digestive disorders, and down syndrome are the factors that will expand the market growth rate. Other factors such as availability of cost effective drugs and rising personal disposable income will positively impact the market's growth rate.
Opportunities
Growing awareness about the less invasive and quicker treatment methods and rising improvements in detection and treatment methodology will further create lucrative market growth opportunities. Rising medical tourism globally and high potential of growth in the untapped market will create enough market growth opportunities.
Restraints/Challenges
However, high costs associated with research and development proficiencies and lack of knowledge about hemorrhoids and misconceptions about them will emerge as one of the biggest restraints for the market. Dearth of awareness and required infrastructural facilities in underdeveloped and backward economies, side effects on health due to the consumption of drugs, time involved in the treatment, and unfavourable conditions arising due to COVID-19 outbreak will further derail the market growth rate. Slow rate of approval for drugs and inhibitors, inadequate knowledge about anorectal disorders in some developing countries and increasing cases of patent expiry will also challenge the market growth rate.
This anorectal disorders treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on anorectal disorders treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Overall, the prevalence for inflammatory bowel disease is 396 cases per 100,000 persons annually. As per GBD 2017 Inflammatory Bowel Disease Collaborators, there were 6.8 million cases of inflammatory bowel disease IBD globally. According to research by NIDDK, 1 out of 20 Americans have hemorrhoids, and 10 million new cases appear each year. There are approximately 70,000 new cases of inflammatory bowel disease being diagnosed every year in the United States
The anorectal disorders treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Anorectal Disorders Treatment Market Scope
The anorectal disorders treatment market is segmented on the basis of disease, treatment, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Disease
- Diarrhea
- Hemorrhoid
- Abscesse
- Fistula
- Itching
- Fissures
- Rectal Prolapse
- Warts
- Others
Treatment
- Drugs
- Surgery
- Others
Route of administration
- Oral
- Parenteral
- Rectal
- Others
End-Users
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
Anorectal Disorders Treatment Market Regional Analysis
The anorectal disorders treatment market is analyzed and market size insights and trends are provided by country, product, disease, treatment, route of administration, end-users, and distribution channel as referenced above.
The countries covered in the anorectal disorders treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the anorectal disorders market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players, well-developed healthcare infrastructure in this region, surge in the awareness towards early diagnosis of the medical condition for better treatment and favorable reimbursement policies.
Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increase in the incidence of gastrointestinal disorders and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Anorectal Disorders Treatment Market Share
The anorectal disorders treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to anorectal disorders treatment market.
Anorectal Disorders Treatment Market Leaders Operating in the Market Are:
- AKORN INC.
- Novartis AG
- Mylan N.V.
- GlaxoSmithKline plc.
- Ferndale Pharma Group, Inc.
- F. Hoffmann-La Roche Ltd
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- GlaxoSmithKline plc
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Merck & Co., Inc
- Sun Pharmaceutical Industries Ltd.
- NATCO Pharma Limited
- LUPIN
- Teva Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- AbbVie Inc.
- Allergan
- Aboott
- Bayer AG
Latest Developments in Anorectal Disorders Treatment Market
- In June 2020, Developeration AB, the Swedish medical company, developed an innovative solution to tackle hemorrhoids less painfully. PexyEazy enables surgical treatment without the need for anesthesia and within 40 % less time
SKU-